Furthermore, Abbott Laboratories (NYSE:ABT) reaffirmed its full-year 2026 comparable sales growth guidance of 6.5% to 7.5%, ...
Abbott Laboratories (NYSE:ABT) delivered strong fiscal Q2 2026 results, beating quarterly estimates and raising its annual ...
The multiyear partnership will connect Abbott’s over-the-counter Lingo sensor and the Google Health app.
Aug 7 (Reuters) - Grail said on Friday the U.S. FDA plans to hold a meeting of outside experts to review its multi-cancer ...
According to MarketsandMarkets™, the Disposable Medical Sensors Market is projected to reach USD 16.13 billion by 2031 from USD 11.86 ...
According to MarketsandMarkets™, the Blood Culture Tests Market is projected to reach USD 8.94 billion by 2031 from USD 6.66 billion in ...
DELRAY BEACH, Fla., Aug. 13, 2026 /PRNewswire/ -- According to MarketsandMarkets, the Disposable Medical Sensors Market is projected to reach USD 16.13 billion by 2031 from USD 11.86 billion in 2026, ...
IDEXX Laboratories, Inc. (Nasdaq: IDXX), a global leader in pet healthcare innovation, today announced the launch of the Catalyst™ proBNP Test, the first and only dual-species, in-clinic test for ...
According to MarketsandMarkets, the Blood Culture Tests Market is projected to reach USD 8.94 billion by 2031 from USD 6.66 billion in 2026 ...
DELRAY BEACH, Fla., Aug. 12, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Cancer Tumor Profiling Market is projected to reach USD 19.87 billion by 2031 from USD 12.02 billion in 2026, at ...
Senate passed a funding bill proposing a delay on most federal restrictions on intoxicating hemp-derived THC products until ...
Outside experts will convene in September to review Grail’s premarket approval application for the MCED blood test. Experts selected for the committee will be key to watch, an analyst said.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results